The macular mapping test: a reliability study

Hannah E. Bartlett*, Leon N. Davies, Frank Eperjesi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Background: Age-related macular degeneration (ARMD) is the leading cause of visual disability in people over 60 years of age in the developed world. The success of treatment deteriorates with increased latency of diagnosis. The purpose of this study was to determine the reliability of the macular mapping test (MMT), and to investigate its potential as a screening tool. Methods: The study population comprised of 31 healthy eyes of 31 participants. To assess reliability, four macular mapping test (MMT) measurements were taken in two sessions separated by one hour by two practitioners, with reversal of order in the second session. MMT readings were also taken from 17 age-related maculopathy (ARM), and 12 AMD affected eyes. Results: For the normal cohort, average MMT scores ranged from 85.5 to 100.0 MMT points. Scores ranged from 79.0 to 99.0 for the ARM group and from 9.0 to 92.0 for the AMD group. MMT scores were reliable to within ± 7.0 points. The difference between AMD affected eyes and controls (z = 3.761, p = < 0.001) was significant. The difference between ARM affected eyes and controls was not significant (z = -0.216, p = 0.829). Conclusion: The reliability data shows that a change of 14 points or more is required to indicate a clinically significant change. This value is required for use of the MMT as an outcome measure in clinical trials. Although there was no difference between MMT scores from ARM affected eyes and controls, the MMT has the advantage over the Amsler grid in that it uses a letter target, has a peripheral fixation aid, and it provides a numerical score. This score could be beneficial in office and home monitoring of AMD progression, as well as an outcome measure in clinical research. © 2005 Bartlett et al; licensee BioMed Central Ltd.

Original languageEnglish
Pages (from-to)18
Number of pages1
JournalBMC Ophthalmology
Issue number18
Publication statusPublished - 2005

Bibliographical note

© 2005 Bartlett et al; licensee BioMed Central Ltd.


  • age-related macular degeneration
  • ARMD
  • treatment
  • diagnosis
  • macular mapping test
  • MMT


Dive into the research topics of 'The macular mapping test: a reliability study'. Together they form a unique fingerprint.

Cite this